C31H42N4O6
Neat
566.70
-20°C
Room Temperature
868540-16-3; L-Phenylalanine, (alphaS)-alpha-((2-(4-morpholinyl)acetyl)amino)benzenebutanoyl-L-leucyl-; L-Phenylalanine and (alphaS)-alpha-[[2-(4-morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-; RefChem:797349; 812-214-9; (S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic acid; CFLZ-567; (alphaS)-alpha-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-L-phenylalanine; MFCD28137654; C31H42N4O6; ((S)-2-(2-morpholinoacetamido)-4-phenylbutanoyl)-L-leucyl-L-phenylalanine; (2S)-2-[[(2S)-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanoyl]amino]-3-phenylpropanoic acid; 1960444-14-7; (S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic acid.; (alphaS)-alpha-((4-Morpholinylacetyl)amino)benzenebutanoyl-L-leucyl-L-phenylalanine; MIVQDKORYUSPTQ-QKDODKLFSA-N; (aS)-a-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-L-phenylalanine; (aS)-a-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-L-phenylalanine;; (S)-2-[(S)-4-Methyl-2-[(S)-2-(2-morpholinoacetamido)-4-phenylbutanamido]pentanamido]-3-phenylpropanoic Acid; Carfilzomib Imputity 56; Carfilzomib intermediate-1
(2S)-2-[[(2S)-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanoyl]amino]-3-phenylpropanoic acid
InChI=1S/C31H42N4O6/c1-22(2)19-26(30(38)34-27(31(39)40)20-24-11-7-4-8-12-24)33-29(37)25(14-13-23-9-5-3-6-10-23)32-28(36)21-35-15-17-41-18-16-35/h3-12,22,25-27H,13-21H2,1-2H3,(H,32,36)(H,33,37)(H,34,38)(H,39,40)/t25-,26-,27-/m0/s1